Blood kinetics of four intraperitoneally administered therapeutic candidate bacteriophages in healthy and neutropenic mice

Microbiology and Immunology

Volumn 53, Issue 5, 2009, Pages 301-304

  Uchiyama, Jumpei ^a,b   Maeda, Yoshihiro ^a   Takemura, Iyo ^a   Chess Williams, Russ ^b   Wakiguchi, Hiroshi ^a   Matsuzaki, Shigenobu ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b BOND UNIVERSITY   (Australia)

Author keywords

Bacteriophage; Blood kinetics; Phage therapy

Indexed keywords

PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIOPHAGE; BACTERIOPHAGE KEP10; BACTERIOPHAGE KPP10; BACTERIOPHAGE PHIEF24C; BACTERIOPHAGE PHIMR11; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; FEMALE; MOUSE; NEUTROPENIA; NONHUMAN; PLASMA CLEARANCE; ANIMAL; BACTERIAL INFECTION; BACTERIUM; BAGG ALBINO MOUSE; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DISEASE MODEL; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; KINETICS; PHYSIOLOGY; VIROLOGY;

ANIMALIA; MUS;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; BLOOD; CAUDOVIRALES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; KINETICS; MICE; MICE, INBRED BALB C; NEUTROPENIA;

EID: 66849125684     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2009.00125.x     Document Type: Article

References (15)

1. Kutter E., Sulakvelidze A. (2005) Bacteriophage therapy in humans. In:Kutter E., Sulakvelidze A., eds. Bacteriophages, Biology and Applications. Boca Raton, FL: CRC Press, pp. 381-436.
2. Merril C.R., Scholl D., Adhya S. (2006) Phage therapy. In:Calendar R., ed. The Bacteriophages, 2nd edn. New York, NY: Oxford University Press, pp. 725-41.
3. Fortuna W., Miedzybrodzki R.,Weber-Dabrowska B., Gorski A. (2008) Bacteriophage therapy in children: facts and prospects. Med Sci Monit 14: RA126-32.
4. Caldwell J. (1996) The importance of drug metabolism studies for efficient drug discovery and development. Drug Metabolism and Pharmacokinetics 11: 119-26.
5. Ackermann H.W. (2007) 5500 phages examined in the electron microscope. Brief review. Arch Virol 152: 227-43.
6. Matsuzaki S., Yasuda M., Nishikawa H., Kuroda M., Ujihara T., Shuin T. et al. (2003) Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phiMR11. J Infect Dis 187: 613-24.
7. Nishikawa H., Yasuda M., Uchiyama J., Rashel M., Maeda Y., Takemura I. et al. (2008) T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections. Arch Virol 153: 507-15.
8. Uchiyama J., Rashel M., Maeda Y., Takemura I., Sugihara S., Akechi K. et al. (2008) Isolation and characterization of a novel Enterococcus faecalis bacteriophage phiEF24C as a therapeutic candidate. FEMS Microbiol Lett 278: 200-6.
9. Uchiyama J., Rashel M., Takemura I.,Wakiguchi H., Matsuzaki S. (2008) In silico and in vivo evaluation of bacteriophage phiEF24C, a candidate for treatment of Enterococcus faecalis infections. Appl Environ Microbiol 74: 4149-63.
10. Watanabe R., Matsumoto T., Sano G., Ishii Y., Tateda K., Sumiyama Y. et al. (2007) Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob Agents Chemother 51: 446-52.
11. Capparelli R., Ventimiglia I., Roperto S., Fenizia D., Iannelli D. (2006) Selection of an Escherichia coli O157:H7 bacteriophage for persistence in the circulatory system of mice infected experimentally. Clin Microbiol Infect 12: 248-53.
12. Merril C.R., Biswas B., Carlton R., Jensen N.C., Creed G.J., Zullo S. et al. (1996) Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci U S A 93: 3188-92.
13. Vitiello C.L., Merril C.R., Adhya S. (2005) An amino acid substitution in a capsid protein enhances phage survival in mouse circulatory system more than a 1000-fold. Virus Res 114: 101-3.
14. Payne R.J., Jansen V.A. (2003) Pharmacokinetic principles of bacteriophage therapy. Clin Pharmacokinet 42: 315-25.
15. Payne R.J., Phil D., Jansen V.A. (2000) Phage therapy: the peculiar kinetics of self-replicating pharmaceuticals. Clin Pharmacol Ther 68: 225-30.